Implication de la voie alternative NF-kappa B dans le cancer de la prostate

Le cancer de la prostate (CaP) est le plus diagnostiqué chez les hommes au Canada et représente le troisième cancer le plus meurtrier au sein de cette population. Malgré l’efficacité des traitements de première ligne, de nombreux patients finiront par développer une résistance et, le cas échéant, verront leur CaP progresser vers une forme plus agressive. Plusieurs paramètres, essentiellement cliniques, permettent de prédire la progression du CaP mais leur sensibilité, encore limitée, implique la nécessité de nouveaux biomarqueurs afin de combler cette lacune. Dans cette optique nous nous intéressons au facteur de transcription NF-κB. Des études réalisées au laboratoire et ailleurs, associent RelA(p65) à un potentiel clinique dans le CaP, soulignant ainsi l’importance de la voie classique NF-κB. L’implication de la voie alternative NF-κB dans la progression du CaP a aussi été suggérée dans une de nos études illustrant la corrélation entre la distribution nucléaire de RelB et le score de Gleason. Alors que la voie classique est largement documentée et son implication dans la progression du CaP établie, la voie alternative, elle, reste à explorer. La présente thèse vise à clarifier l’implication de la voie alternative NF-κB dans le CaP et répond à deux objectifs fixés dans ce but. Le premier objectif fut d’évaluer l’impact de l'activation de la voie alternative NF-κB sur la biologie des cellules cancéreuses prostatiques. L’étude de la surexpression de RelB a souligné les effets de la voie alternative NF-κB sur la prolifération et l'autophagie. Étant ainsi impliquée tant dans la croissance tumorale que dans un processus de plus en plus associée à la progression tumorale, quoique potentiellement létal pour les cellules cancéreuses, son impact sur la tumorigénèse du CaP reste encore difficile à définir. Il n'existe, à ce jour, aucune étude permettant de comparer le potentiel clinique des voies classique et alternative NF-κB. Le second objectif de ce projet fut donc l'analyse conjointe de RelA(p65) et RelB au sein de mêmes tissus de patients atteints de CaP afin de déterminer l'importance clinique des deux signalisations NF-κB, l'une par rapport à l'autre. Le marquage immunofluorescent de RelA(p65) et RelB en a permis l'analyse quantitative et objective par un logiciel d'imagerie. Nos travaux ont confirmé le potentiel clinique associé à RelA(p65). La variable RelA(p65)/RelB s’est, elle, avérée moins informative que RelA(p65). Par contre, aucune corrélation entre RelB et les paramètres cliniques inclus dans l'étude n’est ressortie. En définitive, mon projet de thèse aura permis de préciser l'implication de la voie alternative NF-κB sur la biologie du CaP. Son impact sur la croissance des cellules cancéreuses prostatiques ainsi que sur l'autophagie, dénote l’ambivalence de la voie alternative NF-κB face à la tumorigénèse du CaP. L’étude exhaustive de la signalisation NF-κB souligne davantage l'importance de la voie classique dont l’intérêt clinique est principalement associé au statut de RelA(p65). Ainsi, bien que RelB n’affiche aucun potentiel en tant que biomarqueur exploitable en clinique, l’analyse de l’intervention de la voie alternative NF-κB sur la biologie des cellules cancéreuses prostatiques reste d’intérêt pour la compréhension de son rôle exact dans la progression du CaP.Prostate cancer (PCa) is the most frequently diagnosed cancer and represents the third cause of cancer-death in Canadian men. Despite effective first-line therapies, many patients experience disease recurrence where PCa progresses toward a more aggressive form. Several parameters, largely clinical, have been used to predict the progression of PCa but their accuracy is still limited and implies the need for new biomarkers to fill this gap. Previous research from the laboratory has demonstrated that the transcription factor NF-B, and its nuclear localization, could be such a prognostic biomarker. Studies in our laboratory and elsewhere have correlated RelA(p65) with a clinical progression in PCa, underlining the importance of the classical NF-B pathway. The involvement of the alternative NF-B pathway in the progression of PCa was also suggested in one of our studies showing the correlation between the nuclear distribution of RelB and Gleason score. While the classical pathway is well documented and its involvement in the PCa progression established, the alternative NF-B pathway remains largely unexplored. This thesis describes two research objectives that aims to clarify the involvement of the alternative NF-B pathway in PCa. The first objective assessed the impact of the alternative NF-B pathway activation on the biology of PCa cells. RelB overexpression in 22RV1 PCa cells highlighted an effect of the alternative NF-B pathway on cell proliferation and autophagy. Its dual role in cell growth and a form of cell death requires further study to understand the balance of these in PCa tumorigenesis. To date no study has addressed the comparative prognostic potential of both the classical and alternative NF-B pathways simultaneously. Therefore the second objective of this research project was to analyze both RelA(p65) and RelB at a cellular level in the same tissue of patients with PCa to determine their unique and combined contribution to predicting biochemical recurrence in patients. This analysis was possible through immunofluorescent labeling of RelA (p65) and RelB, and was followed by a quantitative and objective analysis using an appropriate software. Our work confirmed the predictive value of RelA(p65) for biochemical recurrance. Combining RelA(p65) with RelB weakened the association, and RelB on its own was not found to predict biochemical recurrance. Ultimately, the research presented here has clarified the involvement of the alternative NF-B pathway on the biology of PCa. Its impact on the growth of PCa cells as well as autophagy reveals the dual role of the alternative NF-B pathway in PCa tumorigenesis. This exhaustive study of NF-B in PCa tissues further underscores the importance of the classical pathway whose clinical interest is mainly associated with RelA(p65) status. Thus, although RelB shows no potential as a clinically exploitable biomarker, further studies are needed to determine whether RelB contributes, either positively or negatively, and in a temporal fashion, to PCa progression

BTN3A2 Expression in Epithelial Ovarian Cancer Is Associated with Higher Tumor Infiltrating T Cells and a Better Prognosis

BTN3A2/BT3.2 butyrophilin mRNA expression by tumoral cells was previously identified as a prognostic factor in a small cohort of high grade serous epithelial ovarian cancer (HG-EOC). Here, we evaluated the prognostic value of BT3.2 at the protein level in specimen from 199 HG-EOC patients. As the only known role of butyrophilin proteins is in immune regulation, we evaluated the association between BT3.2 expression and intratumoral infiltration of immune cells by immunohistochemistry with specific antibodies against BT3.2, CD3, CD4, CD8, CD20, CD68 and CD206. Epithelial BT3.2 expression was significantly associated with longer overall survival and lower risk of disease progression (HR = 0.651, p = 0.006 and HR = 0.642, p = 0.002, respectively) and significantly associated with a higher density of infiltrating T cells, particularly CD4+ cells (0.272, p<0.001). We also observed a strong association between the relative density of CD206+ cells, as evaluated by the ratio of intratumoral CD206+/CD68+ expression, and risk of disease progression (HR = 1.355 p = 0.044, respectively). In conclusion, BT3.2 protein is a potential prognostic biomarker for the identification of HG-EOC patients with better outcome. In contrast, high CD206+/CD68+ expression is associated with high risk of disease progression. While the role of BT3.2 is still unknown, our result suggest that BT3.2 expression by epithelial cells may modulates the intratumoral infiltration of immune cells

Implication de la voie alternative NF-kappa B dans le cancer de la prostate

Le cancer de la prostate (CaP) est le plus diagnostiqué chez les hommes au Canada et représente le troisième cancer le plus meurtrier au sein de cette population. Malgré l’efficacité des traitements de première ligne, de nombreux patients finiront par développer une résistance et, le cas échéant, verront leur CaP progresser vers une forme plus agressive. Plusieurs paramètres, essentiellement cliniques, permettent de prédire la progression du CaP mais leur sensibilité, encore limitée, implique la nécessité de nouveaux biomarqueurs afin de combler cette lacune. Dans cette optique nous nous intéressons au facteur de transcription NF-κB. Des études réalisées au laboratoire et ailleurs, associent RelA(p65) à un potentiel clinique dans le CaP, soulignant ainsi l’importance de la voie classique NF-κB. L’implication de la voie alternative NF-κB dans la progression du CaP a aussi été suggérée dans une de nos études illustrant la corrélation entre la distribution nucléaire de RelB et le score de Gleason. Alors que la voie classique est largement documentée et son implication dans la progression du CaP établie, la voie alternative, elle, reste à explorer. La présente thèse vise à clarifier l’implication de la voie alternative NF-κB dans le CaP et répond à deux objectifs fixés dans ce but. Le premier objectif fut d’évaluer l’impact de l'activation de la voie alternative NF-κB sur la biologie des cellules cancéreuses prostatiques. L’étude de la surexpression de RelB a souligné les effets de la voie alternative NF-κB sur la prolifération et l'autophagie. Étant ainsi impliquée tant dans la croissance tumorale que dans un processus de plus en plus associée à la progression tumorale, quoique potentiellement létal pour les cellules cancéreuses, son impact sur la tumorigénèse du CaP reste encore difficile à définir. Il n'existe, à ce jour, aucune étude permettant de comparer le potentiel clinique des voies classique et alternative NF-κB. Le second objectif de ce projet fut donc l'analyse conjointe de RelA(p65) et RelB au sein de mêmes tissus de patients atteints de CaP afin de déterminer l'importance clinique des deux signalisations NF-κB, l'une par rapport à l'autre. Le marquage immunofluorescent de RelA(p65) et RelB en a permis l'analyse quantitative et objective par un logiciel d'imagerie. Nos travaux ont confirmé le potentiel clinique associé à RelA(p65). La variable RelA(p65)/RelB s’est, elle, avérée moins informative que RelA(p65). Par contre, aucune corrélation entre RelB et les paramètres cliniques inclus dans l'étude n’est ressortie. En définitive, mon projet de thèse aura permis de préciser l'implication de la voie alternative NF-κB sur la biologie du CaP. Son impact sur la croissance des cellules cancéreuses prostatiques ainsi que sur l'autophagie, dénote l’ambivalence de la voie alternative NF-κB face à la tumorigénèse du CaP. L’étude exhaustive de la signalisation NF-κB souligne davantage l'importance de la voie classique dont l’intérêt clinique est principalement associé au statut de RelA(p65). Ainsi, bien que RelB n’affiche aucun potentiel en tant que biomarqueur exploitable en clinique, l’analyse de l’intervention de la voie alternative NF-κB sur la biologie des cellules cancéreuses prostatiques reste d’intérêt pour la compréhension de son rôle exact dans la progression du CaP.Prostate cancer (PCa) is the most frequently diagnosed cancer and represents the third cause of cancer-death in Canadian men. Despite effective first-line therapies, many patients experience disease recurrence where PCa progresses toward a more aggressive form. Several parameters, largely clinical, have been used to predict the progression of PCa but their accuracy is still limited and implies the need for new biomarkers to fill this gap. Previous research from the laboratory has demonstrated that the transcription factor NF-B, and its nuclear localization, could be such a prognostic biomarker. Studies in our laboratory and elsewhere have correlated RelA(p65) with a clinical progression in PCa, underlining the importance of the classical NF-B pathway. The involvement of the alternative NF-B pathway in the progression of PCa was also suggested in one of our studies showing the correlation between the nuclear distribution of RelB and Gleason score. While the classical pathway is well documented and its involvement in the PCa progression established, the alternative NF-B pathway remains largely unexplored. This thesis describes two research objectives that aims to clarify the involvement of the alternative NF-B pathway in PCa. The first objective assessed the impact of the alternative NF-B pathway activation on the biology of PCa cells. RelB overexpression in 22RV1 PCa cells highlighted an effect of the alternative NF-B pathway on cell proliferation and autophagy. Its dual role in cell growth and a form of cell death requires further study to understand the balance of these in PCa tumorigenesis. To date no study has addressed the comparative prognostic potential of both the classical and alternative NF-B pathways simultaneously. Therefore the second objective of this research project was to analyze both RelA(p65) and RelB at a cellular level in the same tissue of patients with PCa to determine their unique and combined contribution to predicting biochemical recurrence in patients. This analysis was possible through immunofluorescent labeling of RelA (p65) and RelB, and was followed by a quantitative and objective analysis using an appropriate software. Our work confirmed the predictive value of RelA(p65) for biochemical recurrance. Combining RelA(p65) with RelB weakened the association, and RelB on its own was not found to predict biochemical recurrance. Ultimately, the research presented here has clarified the involvement of the alternative NF-B pathway on the biology of PCa. Its impact on the growth of PCa cells as well as autophagy reveals the dual role of the alternative NF-B pathway in PCa tumorigenesis. This exhaustive study of NF-B in PCa tissues further underscores the importance of the classical pathway whose clinical interest is mainly associated with RelA(p65) status. Thus, although RelB shows no potential as a clinically exploitable biomarker, further studies are needed to determine whether RelB contributes, either positively or negatively, and in a temporal fashion, to PCa progression.Le cancer de la prostate (CaP) est le plus diagnostiqué chez les hommes au Canada et représente le troisième cancer le plus meurtrier au sein de cette population. Malgré l’efficacité des traitements de première ligne, de nombreux patients finiront par développer une résistance et, le cas échéant, verront leur CaP progresser vers une forme plus agressive. Plusieurs paramètres, essentiellement cliniques, permettent de prédire la progression du CaP mais leur sensibilité, encore limitée, implique la nécessité de nouveaux biomarqueurs afin de combler cette lacune. Dans cette optique nous nous intéressons au facteur de transcription NF-κB. Des études réalisées au laboratoire et ailleurs, associent RelA(p65) à un potentiel clinique dans le CaP, soulignant ainsi l’importance de la voie classique NF-κB. L’implication de la voie alternative NF-κB dans la progression du CaP a aussi été suggérée dans une de nos études illustrant la corrélation entre la distribution nucléaire de RelB et le score de Gleason. Alors que la voie classique est largement documentée et son implication dans la progression du CaP établie, la voie alternative, elle, reste à explorer. La présente thèse vise à clarifier l’implication de la voie alternative NF-κB dans le CaP et répond à deux objectifs fixés dans ce but. Le premier objectif fut d’évaluer l’impact de l'activation de la voie alternative NF-κB sur la biologie des cellules cancéreuses prostatiques. L’étude de la surexpression de RelB a souligné les effets de la voie alternative NF-κB sur la prolifération et l'autophagie. Étant ainsi impliquée tant dans la croissance tumorale que dans un processus de plus en plus associée à la progression tumorale, quoique potentiellement létal pour les cellules cancéreuses, son impact sur la tumorigénèse du CaP reste encore difficile à définir. Il n'existe, à ce jour, aucune étude permettant de comparer le potentiel clinique des voies classique et alternative NF-κB. Le second objectif de ce projet fut donc l'analyse conjointe de RelA(p65) et RelB au sein de mêmes tissus de patients atteints de CaP afin de déterminer l'importance clinique des deux signalisations NF-κB, l'une par rapport à l'autre. Le marquage immunofluorescent de RelA(p65) et RelB en a permis l'analyse quantitative et objective par un logiciel d'imagerie. Nos travaux ont confirmé le potentiel clinique associé à RelA(p65). La variable RelA(p65)/RelB s’est, elle, avérée moins informative que RelA(p65). Par contre, aucune corrélation entre RelB et les paramètres cliniques inclus dans l'étude n’est ressortie. En définitive, mon projet de thèse aura permis de préciser l'implication de la voie alternative NF-κB sur la biologie du CaP. Son impact sur la croissance des cellules cancéreuses prostatiques ainsi que sur l'autophagie, dénote l’ambivalence de la voie alternative NF-κB face à la tumorigénèse du CaP. L’étude exhaustive de la signalisation NF-κB souligne davantage l'importance de la voie classique dont l’intérêt clinique est principalement associé au statut de RelA(p65). Ainsi, bien que RelB n’affiche aucun potentiel en tant que biomarqueur exploitable en clinique, l’analyse de l’intervention de la voie alternative NF-κB sur la biologie des cellules cancéreuses prostatiques reste d’intérêt pour la compréhension de son rôle exact dans la progression du CaP.Prostate cancer (PCa) is the most frequently diagnosed cancer and represents the third cause of cancer-death in Canadian men. Despite effective first-line therapies, many patients experience disease recurrence where PCa progresses toward a more aggressive form. Several parameters, largely clinical, have been used to predict the progression of PCa but their accuracy is still limited and implies the need for new biomarkers to fill this gap. Previous research from the laboratory has demonstrated that the transcription factor NF-B, and its nuclear localization, could be such a prognostic biomarker. Studies in our laboratory and elsewhere have correlated RelA(p65) with a clinical progression in PCa, underlining the importance of the classical NF-B pathway. The involvement of the alternative NF-B pathway in the progression of PCa was also suggested in one of our studies showing the correlation between the nuclear distribution of RelB and Gleason score. While the classical pathway is well documented and its involvement in the PCa progression established, the alternative NF-B pathway remains largely unexplored. This thesis describes two research objectives that aims to clarify the involvement of the alternative NF-B pathway in PCa. The first objective assessed the impact of the alternative NF-B pathway activation on the biology of PCa cells. RelB overexpression in 22RV1 PCa cells highlighted an effect of the alternative NF-B pathway on cell proliferation and autophagy. Its dual role in cell growth and a form of cell death requires further study to understand the balance of these in PCa tumorigenesis. To date no study has addressed the comparative prognostic potential of both the classical and alternative NF-B pathways simultaneously. Therefore the second objective of this research project was to analyze both RelA(p65) and RelB at a cellular level in the same tissue of patients with PCa to determine their unique and combined contribution to predicting biochemical recurrence in patients. This analysis was possible through immunofluorescent labeling of RelA (p65) and RelB, and was followed by a quantitative and objective analysis using an appropriate software. Our work confirmed the predictive value of RelA(p65) for biochemical recurrance. Combining RelA(p65) with RelB weakened the association, and RelB on its own was not found to predict biochemical recurrance. Ultimately, the research presented here has clarified the involvement of the alternative NF-B pathway on the biology of PCa. Its impact on the growth of PCa cells as well as autophagy reveals the dual role of the alternative NF-B pathway in PCa tumorigenesis. This exhaustive study of NF-B in PCa tissues further underscores the importance of the classical pathway whose clinical interest is mainly associated with RelA(p65) status. Thus, although RelB shows no potential as a clinically exploitable biomarker, further studies are needed to determine whether RelB contributes, either positively or negatively, and in a temporal fashion, to PCa progression

Impact of human papillomavirus on head and neck squamous cell cancers in Gabon

International audienceHead and neck squamous cell cancers are among the most aggressive. Their incidence and mortality rates are relatively lower in Middle Africa than worldwide, but in Gabon, these rates tend to be 2–3 fold higher than in neighboring countries. The main risk factors are alcohol and tobacco consumption. However, in the last decades, there was cumulated evidence that human papillomaviruses were a significant risk factor, particularly for oropharyngeal squamous cell cancer. In Gabon, as elsewhere in Africa, assessment of these 3 risk factors need to be improved to determine their respective role in the development of head and neck squamous cell cancers. The potential differences in alcohol/tobacco consumption habits as well as in infectious ecology between developing and developed countries can make it difficult to transpose current data on this issue. Determining the respective role of alcohol/tobacco consumption and human papillomaviruses in the development of head and neck squamous cell cancers is crucial for the management of these cancers that could become a serious public health issue in Gabon. Human papillomaviruses are not only a risk factor but also a biomarker with promising clinical potential for the follow-up of head and neck squamous cell cancers potentially able to select an adequate treatment. Then, assessing the epidemiological impact of human papillomaviruses in Gabon and in all of Africa would prove useful for the clinical follow-up of head and neck squamous cell cancers, and would also provide essential data to plan a global prevention strategy against head and neck squamous cell cancers due to human papillomaviruses

Human papillomavirus detection using the Abbott RealTime high-risk HPV tests compared with conventional nested PCR coupled to high-throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population

Abstract Background Cervical cancer is the fourth most common malignancy in women worldwide. However, screening with human papillomavirus (HPV) molecular tests holds promise for reducing cervical cancer incidence and mortality in low- and middle-income countries. The performance of the Abbott RealTime High-Risk HPV test (AbRT) was evaluated in 83 cervical smear specimens and compared with a conventional nested PCR coupled to high-throughput sequencing (HTS) to identify the amplicons. Results The AbRT assay detected at least one HPV genotype in 44.57% of women regardless of the grade of cervical abnormalities. Except for one case, good concordance was observed for the genotypes detected with the AbRT assay in the high-risk HPV category determined with HTS of the amplicon generated by conventional nested PCR. Conclusions The AbRT test is an easy and reliable molecular tool and was as sensitive as conventional nested PCR in cervical smear specimens for detection HPVs associated with high-grade lesions. Moreover, sequencing amplicons using an HTS approach effectively identified the genotype of the hrHPV identified with the AbRT test

Contribution of Next-Generation Sequencing to Aquatic and Fish Virology

International audienceThe recent technological advances in nucleic acid sequencing, called next-generation sequencing (NGS), have revolutionized the field of genomics and have also influenced viral research. Aquatic viruses, and especially those infecting fish, have also greatly benefited from NGS technologies, which provide a huge amount of molecular information at a low cost in a relatively short period of time. Here, we review the use of the current high-throughput sequencing platforms with a special focus on the associated challenges (regarding sample preparation and bioinformatics) in their applications to the field of aquatic virology, especially for: (i) discovering novel viruses that may be associated with fish mortalities, (ii) elucidating the mechanisms of pathogenesis, and finally (iii) studying the molecular epidemiology of these pathogens

Molecular characterization of complete genome of a canine distemper virus associated with fatal infection in dogs in Gabon, Central Africa

International audienceCanine distemper (CD) is the most deadly disease in dogs with mortality rates reaching 50%. The pathological agent, the CD virus (CDV), generally causes a severe systemic disease, although the nervous form can coexist with the acute catarrhal form in the same individual. In this study, we describe an outbreak of 18 cases of CD that occurred in 2015 in a German Shepherd dog population in northwestern Gabon. In addition, we determined the sequence of the CDV genotype associated with this fatal distemper infection in Gabon and compared it with other published CDV sequences. The CDV was detected using RT-PCR on cDNA from RNA of harvested brains and other organs. The identification was confirmed by sequencing amplicons. Moreover, we obtained the whole genome sequence using high-throughput sequencing. Phylogenetic analysis revealed that Gabonese CDV strain clustered with European strains belonging to the Europe genotype. This study provided the first molecular detection of the CDV strain associated with this fatal distemper infection in Central Africa region